Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Oral isotretinoin for outcomes after rhinoplasty in patients with thick nasal skin
IRCT20240204060896N1Phase 3Completed
- Sponsor
- Tehran University of Medical Sciences
- Start
- Feb 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label trial of isotretinoin in rhinoplasty (2 arms), sponsored by Tehran University of Medical Sciences. Primary endpoints: Scars and Deformation of cartilage. Started Feb 2024; status: completed.
02
Drugs
isotretinoin
03
Conditions
rhinoplasty
Beyond the preview
Go deeper on IRCT20240204060896N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240204060896N1.